Serum alpha-feto protein (AFP) is commonly used for diagnosis and surveillance of HCC and has been suggested as an independent indicator for prognosis as HCC patients with a high serum AFP levels tend to have shorter survival (Llovet et al., 2012). The gene discussed is AFP; the disease is hepatocellular carcinoma.